MORRIA BIOPHARMACEUTICALS
Morria Biopharmaceuticals Plc, a biopharmaceutical company, engages in the discovery and development of non-steroidal, synthetic anti-inflammatory drugs termed Multi-Functional Anti-Inflammatory Drugs. The company’s products in Phase 2a clinical pipeline include MRX-4, a nasal spray for treating allergic rhinitis or hay fever, as well as MRX-6, a topical cream for treating contact dermatitis, a common type of eczema. Its product candidates in pre-clinical studies comprise OPT-1 for the treatment of conjunctivitis and dry eye; MRX-5 used in the treatment of inflammatory bowel disease; and CFX-1 for the treatment of cystic fibrosis. The company is headquartered in London, the United Kingdom.
MORRIA BIOPHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Care Pharmaceutical
Founded:
2005-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.celsustx.com
Total Employee:
1+
Status:
Active
Contact:
44 (0)20 3322 1321
Email Addresses:
[email protected]
Total Funding:
2.43 M USD
Technology used in webpage:
Amazon Amazon Oregon Region CreativeWork Schema
Similar Organizations
BioActa Ltd.
BioActa Ltd. engages in the discovery and development of novel anti-antigenic compounds.
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Pharmsynthez
Pharmsynthez will bring a number of unique and much-needed drugs to Russian and global markets.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
R&D Biopharmaceuticals
R&D Biopharmaceuticals engages in the pre-clinical and clinical development of small molecules deriving from natural products for diseases.
Triskel Biopharmaceuticals AG
Triskel Biopharmaceuticals AG is specialised in the development of late stage and clearly differentiated biotechnology drugs
Current Employees Featured
Founder
Official Site Inspections
http://www.celsustx.com
- Host name: 162.255.119.67
- IP address: 162.255.119.67
- Location: Los Angeles United States
- Latitude: 34.0318
- Longitude: -118.4252
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 90064
More informations about "Morria Biopharmaceuticals"
Home | Celsus
We are developing anti-complement and anti-inflammatory molecules as life-transforming treatments for a wide range of severe and orphan autoimmune and inflammatory. Celsus …See details»
Celsius Therapeutics is now a part of AbbVie | AbbVie
A trusted leader dedicated to transforming the lives of people with immune-mediated diseases, today and tomorrow. As one company, our ~50,000 employees around the world focus on …See details»
Celsus Therapeutics, Plc | New York NY - Facebook
Celsus Therapeutics, Plc, New York, New York. 3 likes · 1 was here. Celsus Therapeutics is a drug development company focusing on novel...See details»
Celsus Therapeutics Company Profile | Management and
Celsus Therapeutics is an emerging clinical stage company focused on the development of a new class of non-steroidal, synthetic anti-inflammatory drugs termed Multi-Functional Anti …See details»
Celsus Therapeutics - Overview, News & Similar companies
View Celsus Therapeutics (www.celsustx.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
SEC.gov | HOME
Celsus Therapeutics is focused on the development of a novel platform of first-in-class multi-functional anti-inflammatory drugs to improve the lives of people affected by serious and …See details»
Akari Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 646.350.0702 Akari is a biopharmaceutical company focused on developing inhibitors of acute and chronic inflammation, specifically for …See details»
Celsus Therapeutics plc - Life-Sciences-Europe.com
Https://www.celsustx.com. Start: 2013-02-09 existent Industry: BIOTECH : Region: London, Greater London : Country: United Kingdom (GB) Street: One Pancras Square c/o Pearl Cohen …See details»
Celsus Therapeutics Plc | VentureRadar
Celsus Therapeutics Plc VentureRadar profile. Find out more about Celsus Therapeutics Plc, Major Pharmaceuticals.See details»
Carl H. June - Wikipedia
Carl H. June (born 1953) is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory …See details»
Celsus Therapeutics Plc (CLTX) Stock Message Board - InvestorsHub
Find the latest Celsus Therapeutics Plc (CLTX) discussion and analysis from iHub's community of investors.See details»
SEC.gov | HOME
Following the closing of the acquisition, the combined company will be renamed Akari Therapeutics Plc, and the company expects to trade on the NASDAQ Capital Market under the …See details»
Celsus Therapeutics PLC Celsus... - Celsus Therapeutics, Plc
Celsus Therapeutics PLC Celsus Therapeutics Announces the Closing of $9.2 Million Public Offering and Full Exercise of Underwriter’s Option to Purchase...See details»
Telus Corporation - Wikipedia
Telus Corporation is the parent company of Telus Communications, Telus Mobility, Telus Health, and Telus International.Telus Health, which was formerly known as Emergis, an e-Business …See details»
Beau Geste (TV series) - Wikipedia
Benedict Taylor: Michael 'Beau' Geste; Anthony Calf: Digby Geste; Jonathon Morris: John Geste; Andrew Armour: Recruiting Sgt. Major; Sally Baxter: Isobel; Lucy ...See details»
Homepage - Cerus Corporate Site
Nov 13, 2024 · Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company.See details»
Conexus - Conexus Credit Union announces new CEO
Media Release. FOR IMMEDIATE RELEASE. September 20, 2022. Conexus Credit Union announces Celina Philpot as its new CEO (Tuesday, September 20, 2022 – Regina, …See details»
List of assets owned by Corus Entertainment - Wikipedia
This is a list of assets owned by Corus Entertainment, a Canadian multimedia broadcasting company.Approximately 80% of the voting control in Corus is held by the family of JR …See details»
Entrepreneurs' Organization
Learn how our organization began and meet the leadership team working to support entrepreneurs. Browse our suite of benefits designed to help entrepreneurs around the world …See details»
Growing Business to Grow Communities | Catalyste+
Since 1967, we’ve partnered with businesses, governments and community organizations in emerging countries and Indigenous communities in Canada. We aim to strengthen skills and …See details»